Takeda I, Rayno K, Wolfson-Reichlin M, Reichlin M
Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
J Autoimmun. 1999 Dec;13(4):423-8. doi: 10.1006/jaut.1999.0330.
We have investigated the possible cross-reaction of anti-dsDNA antibodies with ribosomal P peptide for several reasons. First, the antibodies frequently occur together, and secondly, they vary similarly with disease activity. Human polyclonal anti-dsDNA antibodies were affinity purified from eight patients and anti-ribosomal P antibodies from two patients with systemic Lupus erythematosus (SLE) who had high titers of anti-dsDNA as well as anti-ribosomal P antibodies. Nine of the 10 sera were totally specific in their reactivity with their cognate antigens. In only one patient did we find a subpopulation of antibodies which cross-reacted with both dsDNA and the carboxyl terminal 22 amino acid peptide. Our results indicate that anti-dsDNA antibodies are heterogeneous and usually do not cross-react with the carboxyl terminal P peptide, but on occasion (1/10) a patient will produce anti-dsDNA antibodies cross-reactive with the carboxyl terminal P peptide.
基于几个原因,我们研究了抗双链DNA(dsDNA)抗体与核糖体P肽之间可能存在的交叉反应。其一,这两种抗体经常同时出现;其二,它们随疾病活动度的变化情况相似。从8例患者中亲和纯化出了人多克隆抗dsDNA抗体,从2例系统性红斑狼疮(SLE)患者中纯化出了抗核糖体P抗体,这2例患者的抗dsDNA及抗核糖体P抗体滴度均很高。10份血清中有9份与各自对应的抗原反应时具有完全特异性。仅在1例患者中,我们发现有一群抗体与dsDNA和羧基末端22个氨基酸肽均发生交叉反应。我们的结果表明,抗dsDNA抗体具有异质性,通常不会与羧基末端P肽发生交叉反应,但偶尔(1/10)会有患者产生与羧基末端P肽发生交叉反应的抗dsDNA抗体。